Benjamin Kopp, MD, MPH, is the Director of the Pulmonary Sickle Cell Program at Children's Healthcare of Atlanta. He also serves as Co-Director of Emory University and Children’s Cystic Fibrosis and Airway Disease Research Center.

Dr. Kopp is a graduate of The Ohio State University School of Medicine. He received his Master of Public Health from The Ohio State University College of Public Health prior to completing his pediatrics residency and pulmonology fellowship at Nationwide Children’s Hospital in Columbus, Ohio. Dr. Kopp then completed post-doctoral training in bacterial pathogenesis and macrophage biology in the laboratories of Amal Amer and Larry Schlesinger.

Dr. Kopp’s area of clinical expertise includes cystic fibrosis, sickle cell lung disease and long-term respiratory sequelae of viral infections such as COVID-19. Dr. Kopp’s NIH-funded research program focuses on innate immune regulation of chronic lung disease in children with cystic fibrosis and sickle cell. An important aspect of this research includes the impact of secondhand tobacco and vape exposure on airway infections and inflammation.

His advocacy and public health efforts center on increasing care for underserved populations and public policy to prevent climate change and environmental exposure impacts on respiratory health.

Learn more about Dr. Kopp’s research.